Asahi Kasei Corporation manufactures, processes, and sells chemical products in Japan and internationally. The company operates through three segments: Material, Homes, and Health Care. It provides caustic soda, chemical fertilizers, nitric acid, ammonia, acrylonitrile, methyl methacrylate, styrene, adipic acid, hexamethylene diamine, AH salt, propionitrile, sodium cyanide, acetonitrile, methacrylonitrile, cyclohexyl methacrylate, cyclohexanol, cyclohexane, and cyclohexene; polymers; chemical intermediates; additives; membranes and systems; clads and anchors; optical and printing materials; electronic materials; and lithium-ion battery and lead-acid battery separators. The company offers cupro fiber, lining fabric, stretch fiber, spunbond nonwovens, cupro nonwoven fabric, microfiber suede, oil-water separator, multifunctional nonwoven, deodorizing nonwoven, heat-press formable thermoplastic nonwoven, noise suppression sheet, nylon filaments, flame-resistant fiber, honeycomb fabric, cellulose nanobead, ecorise, biocradle, and bemliese products, as well as polymers; synthetic rubber; elastomers; kitchen and household products; cleaners; and packaging products. In addition, the company provides electronic devices; and autoclaved aerated concrete, foundation systems, insulation materials, and structural systems and components. Further, it involved in the construction of homes and apartments; management of rental units and condominiums; brokerage of used homes; remodeling; and mortgage financing, asset management services, and insurance products. Additionally, the company provides pharmaceuticals and diagnostic reagents; dialyzers; therapeutic apheresis; biotherapeutics and plasma derivative filters and equipment, and virus removal filters; leukocyte reduction filters; defibrillators, temperature management systems, and data solutions; and UVC LED products. Asahi Kasei Corporation was founded in 1922 and is headquartered in Tokyo, Japan.

Asahi Kasei Corporation

ZOLL Medical Corporation

Celgard

Veloxis Pharmaceuticals, Inc.

NEX Building Group

Crystal IS

Asahi Kasei Plastics North America, Inc.

Sage Automotive Interiors

Asahi Kasei Microdevices (AKM) 

Bionova Scientific

Daramic, LLC

Polypore International

Asaclean® Purging Compounds

Asahi Kasei Bioprocess America, Inc.

Asahi Photoproducts

Asahi Kasei AUTOMOTIVE

Ceolus™ and Celphere™:  Asahi Kasei Microcrystalline Cellulose Products

MICROZA Membrane Filtration - Asahi Kasei

The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 46,000 employees around the world, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care.

OriCiro Genomics

Xeris Pharmaceuticals

Asahi Kasei

msh id	COM:ASAHI-KASEI
symbol	3.41K
name	Asahi Kasei Corporation
homepage url	https://www.asahi-kasei.com
country	JP
sector	Basic Materials
industry	Chemicals
market	STOCKS
employee count	49.3K
crunchbase url	-
linkedin url	-
founders	-

market cap	9.71B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.15
growth cost of revenue	0.15
growth depreciation and amortization	0.19
growth ebitda	-0.16
growth ebitda ratio	-0.25
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	0.01
growth gross profit ratio	-0.09

3407

COM:ASAHI-KASEI

Asahi Kasei Corporation

Last Close

1,077.00

22/11 05:45

Market Cap

1.49T

Beta: -

Volume Today

1.66M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	14.5B
cost of revenue	14.5B
depreciation and amortization	1.03B
ebitda	2.34B
ebitda ratio	0.15
eps	0.75
eps diluted	0.75
operating expenses	3.64B
operating income	1.3B
operating income ratio	0.08

accounts receivables	53.96M
capital expenditure	-1.11B
cash at beginning of period	1.56B
cash at end of period	1.59B
inventory	3.47B
working capital ttm	643.51B

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-